Mankind Pharma Ltd share price logo

Mankind Pharma Ltd

NSE: MANKIND

BSE: 543904

Mid Cap

FMCG Sector

Healthcare Sector

Pharma Sector

₹2368.50

-11.50

(-0.48%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Mankind Pharma shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+70%

Searches for Mankind Pharma on INDmoney have increased by 70% over the last 30 days.

Investment activity on INDmoney

+55.41%

Investment activity in Mankind Pharma among INDmoney users has increased by 55.41% over the last 30 days.

Among the most traded stocks

272nd

Mankind Pharma was the 272nd most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

24 days

INDmoney investors hold Mankind Pharma shares for an average of 24 days.

Key Events for Mankind Pharma

Upcoming Events

Next Results Date26/10/2026

Last Dividend Declared

₹1.00 per share, declared on 31/07/2025

View Dividend History

Mankind Pharma Stock Performance

as on October 10, 2026 at 5:14 am IST

  • Day's Low

    Day's High

    ₹2,342.00
    ₹2,389.80
    downward going graph

    1.12%

    Downside

    0.90%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,909.70
    ₹2,642.00
    downward going graph

    19.37%

    Downside

    11.55%

    Upside

    downward going graph

Mankind Pharma share price movements today

Previous Close
₹2,380.00
Open
₹2,380.00
Volume
3.07L
Upper Circuit
₹2,439.50
Lower Circuit
₹2,297.50
Day's Low - High
₹2,342.00 - ₹2,389.80
52 Week Low - High
₹1,909.70 - ₹2,642.00

Mankind Pharma Historical Returns

1 Month Return
+ 4.39 %
3 Month Return
-5.08 %
1 Year Return
-2.56 %
3 Year Return
+ 34.08 %
5 Year Return
+ 67.33 %

Mankind Pharma Fundamentals

as on October 9, 2026 at 11:44 pm IST

Market Cap

₹97,829.73 Cr

Return on Equity (ROE)

13.27

PE Ratio (TTM)

48.09

Return on capital employed (ROCE)

13.07

Industry PE ratio

51.89

Beta (LTM)

0.66

P/B Ratio

5.05

Dividend Yield

0.05

PEG Ratio

16.53

Quarterly Earnings Growth YOY

29.12

EPS (TTM)

1938.23

Book Value

16301.46

Mankind Pharma Stock Valuation

as on October 9, 2026 at 11:44 pm IST

Mankind Pharma in the last 5 years

  • Overview

  • Trends

Lowest (40.63x)

August 5, 2024

Today (48.09x)

October 8, 2026

Industry (51.89x)

October 8, 2026

Highest (58.15x)

October 7, 2025

LowHigh

Today’s Price to Earnings Ratio: 48.09x

Mankind Pharma Technical Analysis

Track how Mankind Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Neutral

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish6
Bullish6
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bullish
CCI (20)
55.56
Neutral
RSI (14)
51.57
Neutral
Momentum (10)
0
Bearish
ADI (14)
45.14
Bullish
Ultimate Oscillator (7,14,28)
67.25
Neutral

Moving Averages

Name

Value

Action

SMA (20)
2369.6
Bullish
EMA (20)
2370.22
Bullish
VWMA (20)
2370.18
Bullish
SMA (50)
2370.65
Bearish
EMA (50)
2371.3
Bearish
SMA (200)
2370.23
Bullish
EMA (200)
2371.99
Bearish
KAMA (200)
2371.9
Bearish
DEMA (200)
2371.56
Bearish

Mankind Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mankind Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Mankind Pharma Ltd image
Mankind Pharma Ltd
BUY97,829.7313.47%0.651,93814,277
Anthem Biosciences Ltd image
Anthem Biosciences Ltd
BUY48,576.673.89%0.515912,124
Ipca Laboratories Ltd image
Ipca Laboratories Ltd
BUY48,594.5112.89%0.611,1919,646
Gland Pharma Ltd image
Gland Pharma Ltd
BUY50,523.02-3.84%0.521,0276,430
Dr Reddys Laboratories Ltd image
Dr Reddys Laboratories Ltd
HOLD99,911.234.11%0.594,15733,700
See all

Market expectation of Mankind Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

52.63%

Buy

26.32%

Hold

21.05%

Sell

Mankind Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
2,606.95
2,422.24
2,867.85
3,061.43
3,198.79
3,079.37
3,570.35
3,697.16
3,567.2
3,442.93
4,030.59
Other Income
74.73
94.56
107.9
111.63
87.09
253.65
83.05
94.19
75.96
117.28
48.94
Total Income
2,681.68
2,516.8
2,975.75
3,173.06
3,285.88
3,333.02
3,653.4
3,791.35
3,643.16
3,560.21
4,079.53
Expenses
2,000.45
1,836.27
2,196.29
2,216.61
2,382.8
2,400.52
2,723.58
2,775.83
2,754.36
2,536.21
2,974.4
Operating Profit
606.5
585.97
671.56
844.82
815.99
678.85
846.77
921.33
812.84
906.72
1,056.19
Operating Profit Margin %
23.26%
24.19%
23.42%
27.6%
25.51%
22.05%
23.72%
24.92%
22.79%
26.34%
26.2%
Profit Before Interest, Tax and Depreciation
681.23
680.53
779.46
956.45
903.08
932.5
929.82
1,015.52
888.8
1,024
1,105.13
Interest
9.19
9.17
10.84
7.1
220.93
190.54
170.65
169.68
157.2
141.75
109.98
Depreciation
109.72
99.78
102.69
100.49
187.17
230.87
218.68
221.82
222.6
223.08
225.7
Profit Before Tax
562.32
571.58
665.93
848.86
494.98
511.09
540.49
624.02
509
659.17
769.45
Tax Paid
102.51
94.99
122.86
189.98
110.46
86.44
95.87
103.84
95.12
99.75
195.36
Profit After Tax
459.81
476.59
543.07
658.88
384.52
424.65
444.62
520.18
413.88
559.42
574.09
Total Net profit including share of profit / Loss from associate company
459.81
476.59
543.07
658.88
384.52
424.65
444.62
520.18
413.88
559.42
574.09
EPS
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
13.44
13.76
Actual EPS
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
13.44
13.76
Adjusted EPS
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
13.44
13.76
Diluted EPS
11.31
11.74
13.37
16.28
9.44
10.18
10.6
12.38
9.89
13.41
13.74

Mankind Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
5,865.23
6,214.43
7,781.56
8,749.43
10,260.44
12,207.44
14,277.64
Other Income
121.96
182.63
210.48
140.99
296.41
553.56
370.48
Total Income
5,987.19
6,397.06
7,992.03
8,890.42
10,556.85
12,761
14,648.12
Expenses
4,428.42
4,566.33
5,792.2
6,848.8
7,746.76
9,189.51
10,789.98
Operating Profit
1,436.81
1,648.1
1,989.36
1,900.63
2,513.68
3,017.93
3,487.66
Operating Profit Margin %
24.5%
26.52%
25.57%
21.72%
24.5%
24.72%
24.43%
Profit Before Interest, Tax and Depreciation
1,558.77
1,830.73
2,199.83
2,041.63
2,810.09
3,571.49
3,858.14
Interest
21.97
20.15
58.61
44.47
32.75
429.41
639.28
Depreciation
99.06
118.97
166.62
325.92
378.42
621.22
886.18
Profit Before Tax
1,437.74
1,691.61
1,974.6
1,671.24
2,398.92
2,520.86
2,332.68
Tax Paid
381.59
398.58
521.64
361.57
457.15
509.74
394.58
Profit After Tax
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
1,938.1
Total Net profit including share of profit / Loss from associate company
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
1,938.1
EPS
26.36
32.28
35.78
32
47.75
49.28
46.35
Actual EPS
26.36
32.28
35.78
32
47.75
49.28
46.35
Adjusted EPS
26.36
32.28
35.78
32
47.75
49.28
46.35
Diluted EPS
26.36
32.28
35.78
32
47.68
49.19
46.28

Mankind Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
1,069.71
1,137.24
919.78
1,813.3
2,152.44
2,413.38
3,121.29
Cash Flow from Investing Activities
-435.54
-1,221.85
-1,368.67
-1,051.82
-2,080.52
-12,624.07
-180.79
Cash Flow from Financing Activities
-530.74
-7.81
604.62
-739.72
5.27
10,232.56
-2,952.69
Net Cash Flow
103.42
-92.4
155.73
21.76
77.19
21.87
-12.19

Mankind Pharma Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
76.5%
74.88%
74.87%
74.87%
72.71%
72.7%
72.68%
72.67%
72.66%
72.66%
72.63%
DII
9.49%
11.14%
9.95%
9.9%
11.06%
11.48%
11.5%
11.92%
13.25%
14.46%
15.39%
FII
0%
9.87%
11.58%
12.37%
13.34%
12.92%
13.07%
12.84%
11.34%
10.24%
9.45%
Public
6.97%
4.11%
3.61%
2.86%
2.9%
2.9%
2.75%
2.57%
2.75%
2.64%
2.53%
Total Outstanding Shares
40,05,88,440
40,05,88,440
40,06,35,138
40,06,44,138
41,25,66,899
41,25,78,527
41,27,28,748
41,27,58,490
41,28,05,072
41,28,28,328
41,29,95,978
Total Shareholders
1,27,449
1,35,116
1,53,450
1,63,854
1,71,281
1,80,597
1,79,549
1,70,347
1,77,539
1,77,606
1,66,715

Mankind Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Mankind Pharma.

  • Mankind Pharma Ltd Earnings Results

    Mankind Pharma Ltd’s net profit jumped 29.6% since last year same period to ₹568.06Cr in the Q1 2026-2027. On a quarterly growth basis, Mankind Pharma Ltd has generated 2.47% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Mankind Pharma Ltd Dividends July,2025

    In the quarter ending June 2025, Mankind Pharma Ltd has declared dividend of ₹1.00 per share on 31 Jul 2025 - translating a dividend yield of 0.04%.

    Read More about Dividends

Indices Featuring Mankind Pharma Stock

Check stock indices that include Mankind Pharma.

Nifty 200

₹13,062.85

+165.05 (▲1.28%)

Nifty LargeMidcap 250

₹15,600.55

+198.40 (▲1.29%)

Nifty Healthcare

₹15,855.55

+170.90 (▲1.09%)

S&P BSE 150 MidCap

₹15,919.16

+167.10 (▲1.06%)

BSE Healthcare

₹48,828.01

+321.02 (▲0.66%)

BSE 500

₹34,192.47

+357.67 (▲1.06%)

Nifty Midcap 100

₹58,787.30

+904.80 (▲1.56%)

NIFTY PHARMA

₹25,962.05

+138.80 (▲0.54%)

Nifty Midcap 150

₹21,603.25

+291.75 (▲1.37%)

BSE 200

₹10,559.46

+120.18 (▲1.15%)

Nifty Midcap 50

₹16,786.70

+255.80 (▲1.55%)

Nifty MidSmallcap 400

₹20,164.70

+210.90 (▲1.06%)

Nifty 500

₹21,866.65

+250.50 (▲1.16%)

S&P BSE 250 LargeMidCap

₹10,077.61

+113.11 (▲1.14%)

S&P BSE 400 MidSmallCap

₹12,019.57

+100.96 (▲0.85%)

Insights on Mankind Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 3.56K Cr → 4.07K Cr (in ₹), with an average increase of 12.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 408.75 Cr → 568.06 Cr (in ₹), with an average increase of 14.3% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 10.36% to 10.87% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, MANKIND stock has moved up by 4.4%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 2.64% to 2.53% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 10.24% to 9.45% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 72.66% to 72.63% in Jun 2026 quarter

Mankind Pharma Stock Futures & Options Contracts

View the latest movement in Mankind Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.

Mankind Pharma Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 27 Oct ₹2500 Call
October 27, 2026
₹2500
₹19.8
0.65
3.39%
MANKIND 27 Oct ₹2400 Call
October 27, 2026
₹2400
₹49.9
5.9
13.41%
MANKIND 27 Oct ₹2520 Call
October 27, 2026
₹2520
₹17.15
0.75
4.57%
MANKIND 27 Oct ₹2540 Call
October 27, 2026
₹2540
₹14.65
0.6
4.27%

Mankind Pharma Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 27 Oct Fut
October 27, 2026
-
₹2373.2
29.07
1.24%
MANKIND 23 Nov Fut
November 23, 2026
-
₹2368.1
32.7
1.4%
MANKIND 29 Dec Fut
December 29, 2026
-
₹2382
45.79
1.96%

About Mankind Pharma Ltd

Mankind Pharma Ltd. was established in 1991 as a Private Limited Company. In 2005 it was converted to a Public Limited Company and the name changed to Mankind Pharma Limited. The Company is engaged in the development, manufacturing and marketing of a range of pharmaceuticals and consumer healthcare products, and is active in acute and chronic therapeutic areas such as anti-infectives, cardiovascular and gastrointestinal treatments, antidiabetic and neuro/CNS medicines, vitamins, minerals and nutrients. In 2004, they entered the chronic pharmaceutical segment, and have added further products over the years, including ophthalmic products, consumer healthcare products, animal healthcare products and specialty therapeutic divisions. They operate 23 manufacturing facilities across India and had 2181 manufacturing personnel as of March 31, 2021. It is now planning to raise capital through the public offering of 40058844 equity shares, with a total installed capacity of 40.77 billion units across a range of products.

Revenue: ₹4,030.59Cr as on June 2026 (Q1 FY27)
Net Profit: ₹574.09Cr as on June 2026 (Q1 FY27)
Listing date: 09 May, 2023
Chairperson Name: RAMESH CHAND JUNEJA
OrganisationMankind Pharma Ltd
HeadquartersNew Delhi
IndustryPharmaceuticals
CEORAMESH CHAND JUNEJA
E-voting on sharesClick here to vote

FAQs

What is Mankind Pharma share price today?

Mankind Pharma share price today stands at ₹2368.5 as on at the close of the market. Mankind Pharma share today touched a day high of ₹2389.8 and a low of ₹2342.

What is the 52 week high and 52 week low range for Mankind Pharma share?

Mankind Pharma touched a 52 week high of ₹2642 and a 52 week low of ₹1909.7. Mankind Pharma share price today i.e. is closed at ₹2368.5, which is -10.35% down from its 52 week high and 24.02% up from its 52 week low.

What is Mankind Pharma's market capitalisation today?

Mankind Pharma market capitalisation is ₹97,829.73 Cr as on .

How to buy Mankind Pharma shares?

To buy Mankind Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MANKIND or Mankind Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Mankind Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Mankind Pharma trading volume today?

Mankind Pharma trading volume is 3.07L as on . This means that 3.07L shares of Mankind Pharma were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Mankind Pharma shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Mankind Pharma have both increased over the past 30 days, and the average INDmoney investor holds the stock for 24 days. This reflects platform activity only and is not investment advice.